For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, NOV Inc (NYSE: NOV) closed at $15.66 up 2.22% from its previous closing price of $15.32. In other words, the price has increased by $2.22 from its previous closing price. On the day, 4.27 million shares were traded. NOV stock price reached its highest trading level at $15.76 during the session, while it also had its lowest trading level at $15.35.
Ratios:
For a deeper understanding of NOV Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.51. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 2.55. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.34.
On March 24, 2025, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $22.
Evercore ISI Downgraded its Outperform to In-line on January 15, 2025, whereas the target price for the stock was revised from $25 to $18.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 21 ’25 when Kendall Christian S bought 70,000 shares for $14.46 per share. The transaction valued at 1,012,200 led to the insider holds 85,949 shares of the business.
CHRISTY NOVAK bought 21,435 shares of NOV for $316,078 on Nov 24 ’25. On Nov 24 ’25, another insider, CHRISTY NOVAK, who serves as the Officer of the company, bought 450 shares for $15.04 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NOV now has a Market Capitalization of 5815571456 and an Enterprise Value of 6917029888. As of this moment, NOV’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.64, and their Forward P/E ratio for the next fiscal year is 14.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65 while its Price-to-Book (P/B) ratio in mrq is 0.89. Its current Enterprise Value per Revenue stands at 0.788 whereas that against EBITDA is 6.282.
Stock Price History:
The Beta on a monthly basis for NOV is 0.96, which has changed by 0.08961594 over the last 52 weeks, in comparison to a change of 0.15905356 over the same period for the S&P500. Over the past 52 weeks, NOV has reached a high of $16.96, while it has fallen to a 52-week low of $10.65. The 50-Day Moving Average of the stock is 5.73%, while the 200-Day Moving Average is calculated to be 16.75%.
Shares Statistics:
For the past three months, NOV has traded an average of 4.22M shares per day and 3895060 over the past ten days. A total of 366.51M shares are outstanding, with a floating share count of 361.52M. Insiders hold about 0.89% of the company’s shares, while institutions hold 106.22% stake in the company. Shares short for NOV as of 1764288000 were 23536082 with a Short Ratio of 5.58, compared to 1761868800 on 26828130. Therefore, it implies a Short% of Shares Outstanding of 23536082 and a Short% of Float of 14.56.
Dividends & Splits
According to the company, the forward annual dividend rate for NOV is 0.30, from 0.3 in the trailing year. Against a Trailing Annual Dividend Yield of 0.019582247. The stock’s 5-year Average Dividend Yield is 1.25. The current Payout Ratio is 17.15% for NOV, which recently paid a dividend on 2025-12-05 with an ex-dividend date of 2025-12-05. Stock splits for the company last occurred on 2014-06-02 when the company split stock in a 1109:1000 ratio.
Earnings Estimates
As of right now, 10.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.23, with high estimates of $0.28 and low estimates of $0.18.
Analysts are recommending an EPS of between $1.07 and $0.81 for the fiscal current year, implying an average EPS of $0.92. EPS for the following year is $1.12, with 11.0 analysts recommending between $1.27 and $1.01.
Revenue Estimates
A total of 15 analysts believe the company’s revenue will be $2.17B this quarter.It ranges from a high estimate of $2.18B to a low estimate of $2.13B. As of. The current estimate, NOV Inc’s year-ago sales were $2.31BFor the next quarter, 15 analysts are estimating revenue of $2.05B. There is a high estimate of $2.13B for the next quarter, whereas the lowest estimate is $1.98B.
A total of 16 analysts have provided revenue estimates for NOV’s current fiscal year. The highest revenue estimate was $8.65B, while the lowest revenue estimate was $8.59B, resulting in an average revenue estimate of $8.63B. In the same quarter a year ago, actual revenue was $8.87BBased on 18 analysts’ estimates, the company’s revenue will be $8.59B in the next fiscal year. The high estimate is $8.85B and the low estimate is $8.24B.
